Page last updated: 2024-08-23

daunorubicin and glyceraldehyde

daunorubicin has been researched along with glyceraldehyde in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balendiran, GK; Haq, W; Martin, HJ; Maser, E; O'Connor, TR; Verma, M	1
Bains, OS; Grigliatti, TA; Reid, RE; Riggs, KW	1

Other Studies

2 other study(ies) available for daunorubicin and glyceraldehyde

Article	Year
Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers. European journal of pharmacology, 2008, Apr-28, Volume: 584, Issue:2-3 Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzothiazoles; Clofibric Acid; Cysteine; Daunorubicin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyceraldehyde; Humans; Imidazolidines; Kinetics; Mutation; Neoplasms; Oxidation-Reduction; Phthalazines; Pyrimidines; Recombinant Proteins; Serine	2008
Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:3 Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductase Family 1 Member C3; Aldo-Keto Reductases; Biocatalysis; Daunorubicin; Doxorubicin; Gene Frequency; Glyceraldehyde; Humans; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases; Indans; Kinetics; Mitochondrial Proteins; Models, Molecular; NAD(P)H Dehydrogenase (Quinone); Oxidoreductases; Phenanthrenes; Polymorphism, Single Nucleotide; Recombinant Proteins; Vitamin K 3	2010

Article

Year

Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.

European journal of pharmacology, 2008, Apr-28, Volume: 584, Issue:2-3

Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzothiazoles; Clofibric Acid; Cysteine; Daunorubicin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyceraldehyde; Humans; Imidazolidines; Kinetics; Mutation; Neoplasms; Oxidation-Reduction; Phthalazines; Pyrimidines; Recombinant Proteins; Serine

2008

Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin.

The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:3

Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductase Family 1 Member C3; Aldo-Keto Reductases; Biocatalysis; Daunorubicin; Doxorubicin; Gene Frequency; Glyceraldehyde; Humans; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases; Indans; Kinetics; Mitochondrial Proteins; Models, Molecular; NAD(P)H Dehydrogenase (Quinone); Oxidoreductases; Phenanthrenes; Polymorphism, Single Nucleotide; Recombinant Proteins; Vitamin K 3

2010